Introduction
The trade-off we're examining for Inovalon's INDICES clinical data registry is whether to prioritize expanding the breadth of data collected or improving the depth and granularity of existing data points. This decision is crucial for the registry's effectiveness and value proposition. I'll analyze this trade-off by considering the product context, stakeholder impacts, metrics, and potential outcomes.
I'd like to outline my approach to ensure we're aligned on the key areas I'll be covering in my analysis.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Helps align our strategy with customer needs Expected answer: Mix of use cases, some requiring broad data, others needing depth Impact on approach: Would inform which direction provides more immediate value
Why it matters: Directly impacts revenue potential of each option Expected answer: Premium pricing for more granular data Impact on approach: Might lean towards depth if it significantly increases revenue per customer
Why it matters: Indicates which approach aligns better with user needs Expected answer: Varies by user type, but trend towards deeper analysis Impact on approach: Could prioritize depth for key user segments
Why it matters: Affects feasibility and timeline of each option Expected answer: Established processes for both, but new integrations take longer Impact on approach: Might favor depth if it's significantly faster to implement
Why it matters: Influences which option we can execute more effectively Expected answer: Team has more experience with data enrichment Impact on approach: Could lean towards depth to leverage existing expertise
Practice similar questions
Subscribe to access the full answer